02160 CARDIOFLOW-B
- 0.680
- -0.010-1.45%
CARDIOFLOW-B News
CARDIOFLOW-B: 2024 Interim Report
CARDIOFLOW-B: ANNOUNCEMENT OF UNAUDITED INTERIM RESULTSFOR THE SIX MONTHS ENDED JUNE 30, 2024
CARDIOFLOW-B: DATE OF BOARD MEETING
CARDIOFLOW-B: PROFIT FORECAST FOR THE FIRST HALF OF 2024 -SIGNIFICANT REDUCTION IN NET LOSS OFAPPROXIMATELY 63% TO 72%
CARDIOFLOW-B: 2023 Annual Report
CARDIOFLOW-B: ANNUAL RESULTS ANNOUNCEMENTFOR THE YEAR ENDED DECEMBER 31, 2023
CARDIOFLOW-B: DATE OF BOARD MEETING
CARDIOFLOW-B: 2023 Interim Report
CARDIOFLOW-B: ANNOUNCEMENT OF UNAUDITED INTERIM RESULTSFOR THE SIX MONTHS ENDED JUNE 30, 2023
CARDIOFLOW-B: DATE OF BOARD MEETING
CARDIOFLOW-B: 2022 Annual Report
CARDIOFLOW-B: ANNUAL RESULTS ANNOUNCEMENTFOR THE YEAR ENDED DECEMBER 31, 2022
CARDIOFLOW-B: DATE OF BOARD MEETING
CARDIOFLOW-B: PROFIT WARNING
CARDIOFLOW-B: 2022 Interim Report
CARDIOFLOW-B: ANNOUNCEMENT OF UNAUDITED INTERIM RESULTSFOR THE SIX MONTHS ENDED JUNE 30, 2022
CARDIOFLOW-B: DATE OF BOARD MEETING
CARDIOFLOW-B: PROFIT WARNING
CARDIOFLOW-B: 2021 Annual Report
CARDIOFLOW-B: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2021
No Data
